At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Germany based CFO’ operating in the Health Diagnostics space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Chief Financial Officer of Centogene
Richard serves as CFO, providing international expertise in global financial topics at CENTOGENE. His experience and know-how supports CENTOGENE in its continued global growth plans. With over 25 years of experience in international leadership roles covering the full width of governance and risk concepts, his expertise, combined with his extensive change management skills, ensures the finance organization will enable the company to continue its expansive growth path. Richard previously served as Head of Internal Audit at Holcim, a listed multinational company in Switzerland, where he was asked to lead the change of this function from a globally distributed model to a centralized, risk based, model. From 1985 to 2013 he was active in different Audit- and Management-positions at (a.o.) KPMG, in Chicago, Frankfurt, Hong Kong and the Netherlands. During his international audit tenure, Richard was responsible for audits of a multitude of small and large (listed on various stock exchanges, including the US) clients in a wide variety of industries, including the Pharma industry. He developed a new entity on strategic alliances, where he also provided strategy consulting services, including business planning and related funding. As Partner in Charge of one of the offices, he created values-based turn-around. Subsequently, he was HR responsible in the management team for the audit practice of KPMG NL-south. This role led to a further roll out of his management development initiatives in Hong Kong, China and Germany. Furthermore, Richard was involved in IPO`s and Bond issuances on a variety of stock exchanges. He was an active public speaker during his leadership and business development regarding the role of the China Practice, both in Hong Kong-China, and in Europe – where he led the EMA China Practice. Richard graduated as a Dutch CPA with the NBA and Tilburg University – the Netherlands, with further executive education programs at Harvard Business School, Insead (Executive MBA), IMD and IESE.
Follow Richard Stoffelen:
About Centogene: CENTOGENE provides methods and technology for human genetics analysis.
Managing Director and CFO of GNA Biosolutions
Federico holds the post of Managing Director and CFO of GNA Biosolutions. His primary responsibilities are GNA’s finances as well technology-wise for the optoelectronic and software development. Federico has started his entrepreneurial career in high school and thus gained many years of business planning experience. Federico began his undergraduate studies of physics at the University of Munster/Germany and then enrolled at the Universities of Wurzburg/Germany and the University of Texas at Austin, where he earned his Master’s degree in physics in 2003. During his entire studies Federico was a fellow of the German National Academic Foundation (Studienstiftung). Afterwards, Federico moved to Munich/Germany where he worked in the Center for nanoscience and obtained his PhD in physics from Ludwig-Maximilians-Universität in 2008. He is author and co-author of 16 peer-reviewed scientific papers on detection technology.
Follow Federico Bursgens:
About GNA Biosolutions: GNA Biosolutions is a private molecular diagnostics company.
Chief Financial Officer of 4TEEN4 Pharmaceuticals
Follow Martin Reichhuber:
About 4TEEN4 Pharmaceuticals: 4TEEN4 Pharmaceuticals develops innovative biomarkers for diagnosis, prediction and monitoring of acute medical conditions.
Chief Financial Officer of MorphoSys
Jens Holstein joined MorphoSys from Fresenius Kabi AG, where he most recently served as Regional CFO for the region EME (Europe/Middle East) and as Managing Director of Fresenius Kabi Deutschland GmbH. Over the last almost 16 years at Fresenius he had held a variety of financial and general management positions. From 2006 to 2010, he was Regional Chief Financial Officer of Fresenius Kabi Asia Pacific Ltd., based in Hong Kong. Prior to this appointment, Mr. Holstein was Managing Director of Fresenius ProServe GmbH and Finance Director and Labor Director of the company’s subsidiary Wittgensteiner Kliniken AG. Earlier positions within Fresenius included General Manager of hospitalia care GmbH, Commercial Manager of the Projects & Service business unit of Fresenius AG and Commercial Manager of hospitalia international GmbH. Prior to joining Fresenius, Mr. Holstein spent several years in the consulting industry, with positions in Frankfurt and London. Mr. Holstein holds a Diploma in Business Administration from University of Münster. He currently does not hold any other board memberships.
Follow Jens Holstein:
About MorphoSys: MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
Managing Director & CFO of Sividon Diagnostics
1999: project manager for the Bio-Gen-Tec-NRW state initiative; financing of promising biotech start-ups 2001: business development and license management for a medium-sized pharmaceutical company 2002: International Marketing and Sales at DASGIP AG. 2005: Investment Manager at Intelligent Venture Capital GmbH; focus on life science and technology-based start-ups. 2008: CEO of Intelligent Venture Consulting AG. Active support for entrepreneurs on strategic issues in marketing, sales and finance Since 11/2010: Managing Partner of Sividon Diagnostics GmbH
Follow Georg Kox:
About Sividon Diagnostics: Sividon Diagnostics develops advanced diagnostics that facilitate therapeutic discovery.